Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Other financing activities (2023 - 2026)

TriSalus Life Sciences has reported Other financing activities over the past 4 years, most recently at $263000.0 for Q1 2026.

  • For Q1 2026, Other financing activities fell 49.42% year-over-year to $263000.0; the TTM value through Mar 2026 reached $243000.0, down 92.21%, while the annual FY2025 figure was $500000.0, 80.77% down from the prior year.
  • Other financing activities for Q1 2026 was $263000.0 at TriSalus Life Sciences, up from -$20000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $2.6 million in Q4 2024 and troughed at -$2.6 million in Q3 2024.
  • A 4-year average of $336300.0 and a median of $231316.5 in 2023 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: skyrocketed 1398.88% in 2024 and later tumbled 100.77% in 2025.
  • Year by year, Other financing activities stood at -$199633.0 in 2023, then skyrocketed by 1402.39% to $2.6 million in 2024, then tumbled by 100.77% to -$20000.0 in 2025, then skyrocketed by 1415.0% to $263000.0 in 2026.
  • Business Quant data shows Other financing activities for TLSI at $263000.0 in Q1 2026, -$20000.0 in Q4 2025, and -$1.0 million in Q3 2025.